CARLSBAD, CA — August 3, 2020 — ALASTIN Skincare, Inc. (www.alastin.com) —a specialty aesthetics company dedicated to developing and marketing innovative, clinically-tested physician-dispensed skin care products with proprietary TriHex Technology® that enhance, protect, and maintain healthy skin for a lifetime—has announced the appointment of Amber Edwards to the position of Chief Commercial Officer, effective July 31, 2020
Ms. Edwards holds a proven track record of successful business leadership and global development of leading brands in the medical aesthetics arena. Ms. Edwards most recently served as President of North America for Sinclair Pharma. Prior to Sinclair, she was at Allergan, Inc. where she was the Vice President of International Strategic Marketing, Medical Aesthetics Franchise, in the UK. She also has experience with Allergan in the US, in both aesthetic and therapeutic areas. Ms. Edwards began her career in Sales and Marketing roles at Pfizer.
“We are extremely pleased to have Amber Edwards join ALASTIN as a key member of the executive team to lead our US and International commercialization activities as we continue the rapid growth of our company”, said Diane S. Goostree, President and CEO of ALASTIN Skincare. “Amber’s strategic perspectives and global experience will be extremely helpful as we leverage our innovative science and products and expand our footprint in the aesthetic marketplace.”
Ms. Edwards stated, “I am thrilled to join an organization that has made such a notable mark in a crowded segment, and at a time they are experiencing tremendous opportunity and momentum. ALASTIN has demonstrated a commitment to science and ultimately to patients, identifying an innovative approach to helping physicians maximize patient results. I believe they have only scratched the surface and am honored to lead the commercial path forward.”